Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer Cell International

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1186/s12935-024-03371-9

License

CC-BY

Other Formats

PDF